# Richardson Electronics, LTD.: financial statements, quarterly

RELL · Nasdaq · CIK 355948 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends May 29

Pages: [Overview](/companies/rell.md) · [Financials](/companies/rell/financials.md) · [Filings](/companies/rell/filings.md) · [Insiders](/companies/rell/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rell/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-12-02) | Q3 FY2024 (2024-03-02) | Q4 FY2024 (2024-06-01) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-03-01) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-30) | Q2 FY2026 (2025-11-29) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-30) | Q1 FY2027 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [44.1](/filings/0000950170-25-101785.md) | [52.4](/filings/0000950170-25-101785.md) | [47.4](/filings/0000950170-25-101785.md) | [53.7](/filings/0001193125-25-235681.md) | [49.5](/filings/0001193125-26-007399.md) | [53.8](/filings/0001193125-26-149207.md) | [51.9](/filings/0000950170-25-101785.md) | [54.6](/filings/0000355948-26-000019.md) | [52.3](/filings/0001193125-26-007399.md) | [55.5](/filings/0001193125-26-149207.md) | [66.2 d](/filings/0000355948-26-000002.md) | [64.9](/filings/0000355948-26-000019.md) |
| Cost of revenue | $m | [31.6](/filings/0000950170-24-003844.md) | [36.9](/filings/0000950170-24-043629.md) | [32.7 d](/filings/0000355948-26-000002.md) | [37.3](/filings/0001193125-25-235681.md) | [34.2](/filings/0001193125-26-007399.md) | [37.1](/filings/0001193125-26-149207.md) | [35.5 d](/filings/0000355948-26-000002.md) | [37.7](/filings/0000355948-26-000019.md) | [36.2](/filings/0001193125-26-007399.md) | [37.8](/filings/0001193125-26-149207.md) | [45.5 d](/filings/0000355948-26-000002.md) | [42.4](/filings/0000355948-26-000019.md) |
| Gross profit | $m | [12.5](/filings/0000950170-25-101785.md) | [15.4](/filings/0000950170-25-101785.md) | [14.7](/filings/0000950170-25-101785.md) | [16.4](/filings/0001193125-25-235681.md) | [15.3](/filings/0001193125-26-007399.md) | [16.7](/filings/0001193125-26-149207.md) | [16.4](/filings/0000950170-25-101785.md) | [16.9](/filings/0000355948-26-000019.md) | [16.1](/filings/0001193125-26-007399.md) | [17.7](/filings/0001193125-26-149207.md) | [20.7 d](/filings/0000355948-26-000002.md) | [22.5](/filings/0000355948-26-000019.md) |
| Selling, general and administrative | $m | [14.5](/filings/0000950170-25-003888.md) | [14.4](/filings/0000950170-25-052737.md) | [14.8 d](/filings/0000355948-26-000002.md) | [16.1](/filings/0001193125-25-235681.md) | [16.0](/filings/0001193125-26-007399.md) | [14.5](/filings/0001193125-26-149207.md) | [15.6 d](/filings/0000355948-26-000002.md) | [16.0](/filings/0000355948-26-000019.md) | [15.9](/filings/0001193125-26-007399.md) | [16.2](/filings/0001193125-26-149207.md) | [17.6 d](/filings/0000355948-26-000002.md) | [17.4](/filings/0000355948-26-000019.md) |
| Operating income | $m | [(2.0)](/filings/0000950170-25-003888.md) | [1.0](/filings/0000950170-25-052737.md) | [(0.1) d](/filings/0000355948-26-000002.md) | [0.3](/filings/0001193125-25-235681.md) | [(0.7)](/filings/0001193125-26-007399.md) | [(2.7)](/filings/0001193125-26-149207.md) | [0.6 d](/filings/0000355948-26-000002.md) | [1.0](/filings/0000355948-26-000019.md) | [0.1](/filings/0001193125-26-007399.md) | [1.5](/filings/0001193125-26-149207.md) | [3.9 d](/filings/0000355948-26-000002.md) | [5.1](/filings/0000355948-26-000019.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.5)](/filings/0000950170-25-003888.md) | [0.2](/filings/0000950170-25-052737.md) | [(0.0) d](/filings/0000355948-26-000002.md) | [0.1](/filings/0001193125-25-235681.md) | [(0.3)](/filings/0001193125-26-007399.md) | [(1.0)](/filings/0001193125-26-149207.md) | [0.9 d](/filings/0000355948-26-000002.md) | [0.4](/filings/0000355948-26-000019.md) | [(0.1)](/filings/0001193125-26-007399.md) | [0.3](/filings/0001193125-26-149207.md) | [0.4 d](/filings/0000355948-26-000002.md) | [1.0](/filings/0000355948-26-000019.md) |
| Net income | $m | [(1.8)](/filings/0000950170-25-101785.md) | [0.8](/filings/0000950170-25-101785.md) | [(0.1)](/filings/0000950170-25-101785.md) | [0.6](/filings/0001193125-25-235681.md) | [(0.8)](/filings/0001193125-26-007399.md) | [(2.1)](/filings/0001193125-26-149207.md) | [1.1](/filings/0000950170-25-101785.md) | [1.9](/filings/0000355948-26-000019.md) | [(0.1)](/filings/0001193125-26-007399.md) | [0.9](/filings/0001193125-26-149207.md) | [3.7 d](/filings/0000355948-26-000002.md) | [4.1](/filings/0000355948-26-000019.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-12-02) | Q3 FY2024 (2024-03-02) | FY2024 (2024-06-01) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-03-01) | FY2025 (2025-05-31) | Q1 FY2026 (2025-08-30) | Q2 FY2026 (2025-11-29) | Q3 FY2026 (2026-02-28) | FY2026 (2026-05-30) | Q1 FY2027 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [22.8](/filings/0000950170-24-003844.md) | [18.9](/filings/0000950170-24-043629.md) | [24.3](/filings/0000950170-25-101785.md) | [23.0](/filings/0000950170-24-114027.md) | [26.6](/filings/0000950170-25-003888.md) | [36.7](/filings/0000950170-25-052737.md) | [35.9](/filings/0000355948-26-000002.md) | [35.7](/filings/0001193125-25-235681.md) | [33.1](/filings/0001193125-26-007399.md) | [29.5](/filings/0001193125-26-149207.md) | [31.8](/filings/0000355948-26-000019.md) | [36.9](/filings/0000355948-26-000019.md) |
| Current assets | $m | [167](/filings/0000950170-24-003844.md) | [163](/filings/0000950170-24-043629.md) | [162](/filings/0000950170-25-101785.md) | [167](/filings/0000950170-24-114027.md) | [166](/filings/0000950170-25-003888.md) | [164](/filings/0000950170-25-052737.md) | [166](/filings/0000355948-26-000002.md) | [170](/filings/0001193125-25-235681.md) | [172](/filings/0001193125-26-007399.md) | [170](/filings/0001193125-26-149207.md) | [173](/filings/0000355948-26-000019.md) | [180](/filings/0000355948-26-000019.md) |
| Total assets | $m | [196](/filings/0000950170-24-003844.md) | [194](/filings/0000950170-24-043629.md) | [192](/filings/0000950170-25-101785.md) | [198](/filings/0000950170-24-114027.md) | [195](/filings/0000950170-25-003888.md) | [190](/filings/0000950170-25-052737.md) | [196](/filings/0000355948-26-000002.md) | [200](/filings/0001193125-25-235681.md) | [202](/filings/0001193125-26-007399.md) | [200](/filings/0001193125-26-149207.md) | [202](/filings/0000355948-26-000019.md) | [212](/filings/0000355948-26-000019.md) |
| Current liabilities | $m | [36.0](/filings/0000950170-24-003844.md) | [32.3](/filings/0000950170-24-043629.md) | [32.0](/filings/0000950170-25-101785.md) | [36.3](/filings/0000950170-24-114027.md) | [36.7](/filings/0000950170-25-003888.md) | [34.7](/filings/0000950170-25-052737.md) | [36.8](/filings/0000355948-26-000002.md) | [38.7](/filings/0001193125-25-235681.md) | [41.4](/filings/0001193125-26-007399.md) | [37.8](/filings/0001193125-26-149207.md) | [36.4](/filings/0000355948-26-000019.md) | [38.6](/filings/0000355948-26-000019.md) |
| Total liabilities | $m | [37.8](/filings/0000950170-24-003844.md) | [35.0](/filings/0000950170-24-043629.md) | [34.5](/filings/0000950170-25-101785.md) | [38.8](/filings/0000950170-24-114027.md) | [39.0](/filings/0000950170-25-003888.md) | [36.9](/filings/0000950170-25-052737.md) | [39.2](/filings/0000355948-26-000002.md) | [40.7](/filings/0001193125-25-235681.md) | [43.3](/filings/0001193125-26-007399.md) | [39.6](/filings/0001193125-26-149207.md) | [38.3](/filings/0000355948-26-000019.md) | [42.5](/filings/0000355948-26-000019.md) |
| Shareholders' equity | $m | [159](/filings/0000950170-25-052737.md) | [159](/filings/0000950170-25-052737.md) | [158](/filings/0000355948-26-000002.md) | [159](/filings/0001193125-26-007399.md) | [156](/filings/0001193125-26-149207.md) | [153](/filings/0001193125-26-149207.md) | [157](/filings/0000355948-26-000019.md) | [159](/filings/0000355948-26-000019.md) | [158](/filings/0001193125-26-149207.md) | [160](/filings/0001193125-26-149207.md) | [164](/filings/0000355948-26-000019.md) | [169](/filings/0000355948-26-000019.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-12-02) | Q3 FY2024 (2024-03-02) | Q4 FY2024 (2024-06-01) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-03-01) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-30) | Q2 FY2026 (2025-11-29) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-30) | Q1 FY2027 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [800](/filings/0000950170-25-003888.md) | [(2,531)](/filings/0000950170-25-052737.md) | [7,240 d](/filings/0000355948-26-000002.md) | [412](/filings/0001193125-25-235681.md) | [5,465](/filings/0001193125-26-007399.md) | [4,601](/filings/0001193125-26-149207.md) | [74.0 d](/filings/0000355948-26-000002.md) | [1,367](/filings/0000355948-26-000019.md) | [(99.0)](/filings/0001193125-26-007399.md) | [(2,650)](/filings/0001193125-26-149207.md) | [2,144 d](/filings/0000355948-26-000002.md) | [5,873](/filings/0000355948-26-000019.md) |
| Capital expenditure | $k | [1,515](/filings/0000950170-25-003888.md) | [401](/filings/0000950170-25-052737.md) | [984 d](/filings/0000355948-26-000002.md) | [926](/filings/0001193125-25-235681.md) | [517](/filings/0001193125-26-007399.md) | [549](/filings/0001193125-26-149207.md) | [819 d](/filings/0000355948-26-000002.md) | [1,025](/filings/0000355948-26-000019.md) | [1,606](/filings/0001193125-26-007399.md) | [759](/filings/0001193125-26-149207.md) | [993 d](/filings/0000355948-26-000002.md) | [1,697](/filings/0000355948-26-000019.md) |
| Dividends paid | $k | [845](/filings/0000950170-25-003888.md) | [844](/filings/0000950170-25-052737.md) | [844 d](/filings/0000355948-26-000002.md) | [850](/filings/0001193125-25-235681.md) | [853](/filings/0001193125-26-007399.md) | [852](/filings/0001193125-26-149207.md) | [852 d](/filings/0000355948-26-000002.md) | [857](/filings/0000355948-26-000019.md) | [859](/filings/0001193125-26-007399.md) | [859](/filings/0001193125-26-149207.md) | [864 d](/filings/0000355948-26-000002.md) | [880](/filings/0000355948-26-000019.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2023 (2022-11-26) | Q3 FY2023 (2023-02-25) | Q1 FY2024 (2023-09-02) | Q2 FY2024 (2023-12-02) | Q3 FY2024 (2024-03-02) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-03-01) | Q1 FY2026 (2025-08-30) | Q2 FY2026 (2025-11-29) | Q3 FY2026 (2026-02-28) | Q1 FY2027 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.5](/filings/0000950170-24-003844.md) | [12.7](/filings/0000950170-24-043629.md) | [12.5](/filings/0000950170-24-114027.md) | [12.2](/filings/0000950170-25-003888.md) | [12.4](/filings/0000950170-25-052737.md) | [12.4](/filings/0001193125-25-235681.md) | [12.3](/filings/0001193125-26-007399.md) | [12.3](/filings/0001193125-26-149207.md) | [12.5](/filings/0000355948-26-000019.md) | [12.5](/filings/0001193125-26-007399.md) | [12.7](/filings/0001193125-26-149207.md) | [13.0](/filings/0000355948-26-000019.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,796,094 at 2018-04-10, from the cover of the [10-Q filed 2018-04-12](/filings/0001387131-18-001554.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.